Stifel Financial
CUE icon

Stifel Financial’s Cue Biopharma CUE Stock Holding History

Stifel Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.7K Hold
8,219
– – ﹤0.01% 3570
2025
Q4 		$75.3K Buy
8,219
+1,667
+25% +$30.6K ﹤0.01% 3508
2025
Q3 		$141K Hold
6,552
– – ﹤0.01% 3405
2025
Q2 		$134K Sell
6,552
-234
-3% -$4.99K ﹤0.01% 3328
2025
Q1 		$185K Sell
6,786
-259
-4% -$9.62K ﹤0.01% 3205
2024
Q4 		$230K Buy
7,045
+571
+9% +$21.5K ﹤0.01% 3101
2024
Q3 		$147K Buy
6,474
+8
+0.1% +$173 ﹤0.01% 3190
2024
Q2 		$241K Buy
6,466
+46
+0.7% +$2.27K ﹤0.01% 3022
2024
Q1 		$364K Sell
6,420
-46
-0.7% -$3.25K ﹤0.01% 2794
2023
Q4 		$512K Buy
6,466
+1,559
+32% +$111K ﹤0.01% 2544
2023
Q3 		$339K Sell
4,907
-4
-0.1% -$391 ﹤0.01% 2721
2023
Q2 		$538K Buy
4,911
+29
+0.6% +$3.41K ﹤0.01% 2476
2023
Q1 		$523K Buy
4,882
+537
+12% +$51.2K ﹤0.01% 2488
2022
Q4 		$372K Buy
4,345
+2,123
+96% +$194K ﹤0.01% 2638
2022
Q3 		$148K Hold
2,222
– – ﹤0.01% 3029
2022
Q2 		$165K Hold
2,222
– – ﹤0.01% 3059
2022
Q1 		$325K Hold
2,222
– – ﹤0.01% 2834
2021
Q4 		$754K Buy
2,222
+26
+1% +$10.1K ﹤0.01% 2324
2021
Q3 		$960K Hold
2,196
– – ﹤0.01% 2130
2021
Q2 		$768K Hold
2,196
– – ﹤0.01% 2293
2021
Q1 		$804K Hold
2,196
– – ﹤0.01% 2140
2020
Q4 		$824K Hold
2,196
– – ﹤0.01% 1986
2020
Q3 		$991K Hold
2,196
– – ﹤0.01% 1636
2020
Q2 		$1.61M Buy
2,196
+334
+18% +$242K ﹤0.01% 1270
2020
Q1 		$792K Hold
1,862
– – ﹤0.01% 1573
2019
Q4 		$887K Hold
1,862
– – ﹤0.01% 1913
2019
Q3 		$471K Hold
1,862
– – ﹤0.01% 2202
2019
Q2 		$502K Buy
+1,862
New +$463K ﹤0.01% 2204

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Stifel Financial's CUE Position: Q1 2026 in Review

Stifel Financial held its Cue Biopharma (CUE) position steady in Q1 2026 at 8,219 shares worth $56.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

Stifel Financial first reported a position in CUE in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.61M in Q2 2020. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Stifel Financial held 8,219 shares of Cue Biopharma worth $56.7K as of Q1 2026.
  • Stifel Financial left its Cue Biopharma share count unchanged in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3570 holding.
  • Stifel Financial first reported a position in Cue Biopharma in Q2 2019 and has held it in 28 quarters since.
  • Stifel Financial's Cue Biopharma position peaked at $1.61M in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.